Immuneel, Tata Memorial Centre partner to advance cell and gene therapy research

Among the first projects identified under the partnership is a Phase 2 extension study evaluating the safety and efficacy of IMN-003A cell therapy in adult and paediatric patients with relapsed or refractory CD19-positive B-cell malignancies

Raccontata dathehindubusinessline.com